Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New cyanopyridine-based scaffold as PIM-1 inhibitors and apoptotic inducers: Synthesis and SARs study
Amel M. Farrag, Mona H. Ibrahim, Ahmed B. M. Mehany, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104378-104378
Closed Access | Times Cited: 24

Showing 24 citing articles:

Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles
Li Chen, Wuyu Mao, Changyu Ren, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 1, pp. 38-64
Closed Access | Times Cited: 11
New molecular hybrids integrated with quinoxaline and pyrazole structural motifs: VGFR2 inhibitors and apoptosis inducers
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108182-108182
Closed Access
Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106735-106735
Closed Access | Times Cited: 10
Theoretical studies, anticancer activity, and photovoltaic performance of newly synthesized carbazole-based dyes
Mohamed R. Elmorsy, Ehab Abdel‐Latif, Hatem E. Gaffer, et al.
Journal of Molecular Structure (2022) Vol. 1255, pp. 132404-132404
Closed Access | Times Cited: 17
A review: Biological activities of novel cyanopyridine derivatives
Yurou Wu, Tao Wu, Yong Huang
Archiv der Pharmazie (2023) Vol. 356, Iss. 7
Closed Access | Times Cited: 7
The anti-breast cancer activity of indeno[1,2-b]pyridin-5-one and their hydrazonal precursors endowed with anti-CDK-2 enzyme activity
Sami A. Al‐Hussain, Thoraya A. Farghaly, Mona H. Ibrahim, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136692-136692
Closed Access | Times Cited: 7
Development of novel cyanopyridines as PIM-1 kinase inhibitors with potent anti-prostate cancer activity: Synthesis, biological evaluation, nanoparticles formulation and molecular dynamics simulation
Mona H. Ibrahim, Marwa F. Harras, Shaimaa K. Mostafa, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106122-106122
Closed Access | Times Cited: 11
Mimicry of sorafenib: novel diarylureas as VEGFR2 inhibitors and apoptosis inducers in breast cancer
Magda M. F. Ismail, Ebtehal M. Husseiny, Mona H. Ibrahim
New Journal of Chemistry (2023) Vol. 47, Iss. 24, pp. 11565-11576
Closed Access | Times Cited: 6
Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
RSC Advances (2023) Vol. 13, Iss. 45, pp. 31908-31924
Open Access | Times Cited: 6
Cyanopyridinone- and Cyanopyridine-Based Cancer Cell Pim-1 Inhibitors: Design, Synthesis, Radiolabeling, Biodistribution, and Molecular Modeling Simulation
Basem Mansour, Yomna A. Salem, Khaled M. Attallah, et al.
ACS Omega (2023) Vol. 8, Iss. 22, pp. 19351-19366
Open Access | Times Cited: 5
Targeting PIM kinases in cancer therapy: An update on pharmacological small-molecule inhibitors
Siwei Chen, Yu‐Shang Yang, Yong Yuan, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116016-116016
Closed Access | Times Cited: 5
Nicotinonitrile as an essential scaffold in medicinal chemistry: an updated review (2015– present)
Heba Hassan, Mohamed Hisham, M.S. Osman, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2022) Vol. 6, Iss. 1, pp. 1-11
Open Access | Times Cited: 9
Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer
Anushka Sharma, Rahul Dubey, Vikas Asati, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors
Bahgat R. M. Hussein, Hayam H. Mohammed, Eman A. Ahmed, et al.
Molecular Diversity (2024)
Open Access | Times Cited: 1
Design and Synthesis of Novel Pyridine-Based Compounds as Potential PIM-1 Kinase Inhibitors, Apoptosis, and Autophagy Inducers Targeting MCF-7 Cell Lines: In Vitro and In Vivo Studies
Shrouk M. Shaban, Elsayed H. Eltamany, Ahmed T. A. Boraei, et al.
ACS Omega (2023) Vol. 8, Iss. 49, pp. 46922-46933
Open Access | Times Cited: 4
Optimization of 4,6-Disubstituted Pyrido[3,2-d]pyrimidines as Dual MNK/PIM Inhibitors to Inhibit Leukemia Cell Growth
Yu Han, Huimin Zhang, Shuxiang Wang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13719-13735
Closed Access | Times Cited: 10
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity
Moataz A. Shaldam, Ahmed F. Khalil, Hadia Almahli, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access | Times Cited: 3
What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors
Phil M. M. Hochban, Lukas Heyder, A. Heine, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 6
Open Access
Proviral integration site for Moloney murine leukemia virus-1 (PIM-1) kinase inhibitors
Vinod Kumar Gurjar, Vivek Shrivastava, Shweta Jain, et al.
Elsevier eBooks (2024), pp. 255-321
Closed Access
New N-amino-5-cyano-6-pyridones as antimicrobial small molecules endowed with DNA gyrase a inhibitory activity: design, one-pot synthesis, biological assessment and in silico insights
Omkulthom Al Kamaly, Amel S. Younes, Marwa F. Harras, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access
Synthesis of novel pyridine and pyrazolyl pyridine conjugates with potent cytotoxicity against HepG2 cancer cells as PIM-1 kinase inhibitors and caspase activators
Mohamed S. Nafie, Ahmed Hamza, Ahmed H. Moustafa, et al.
RSC Advances (2024) Vol. 14, Iss. 53, pp. 39381-39394
Open Access
Synthesis of novel N-phenylbenzamide-thiazoles with potential DHFR inhibitory activity: Antibacterial activity, DFT and ADMET studies
Salwa Magdy Eldaly, Hamdi M. Hassaneen, Nadia Hanafy Metwally
Journal of Molecular Structure (2024), pp. 141204-141204
Closed Access
TARGETTING THE 3BGQ - PIM1 KINASE INTERACTION WITH A SERIES OF NOVEL DITHIOCARBAMATE SUBSTITUTED 2-OXOINDOLE DERIVATIVES- IN SILICO STUDIES
Saritha Jyostna Tangeda, Muni Sireesha SUNKARA, Dharani ANNEPALLY, et al.
Ankara Universitesi Eczacilik Fakultesi Dergisi (2022), pp. 86-102
Open Access | Times Cited: 1
Cyanopyridine as a privileged scaffold in drug discovery
Yingjie Chang, Xuben Hou, Hao Fang
Elsevier eBooks (2023), pp. 163-198
Closed Access
Page 1

Scroll to top